Read More

What Is The Trump Factor? Justice Dept’s Impact On Cannabis Rescheduling, Stocks And Investments

Equity research firm Zuanic & Associates convened a panel in mid-June featuring industry experts to dissect the ongoing cannabis rescheduling efforts in the US. They provided a comprehensive outlook on the rescheduling process, expected to conclude with the publication of the Final Rule in the Federal Register by November 2024.

CRLBF

Read More

Cannabis Stocks Under $2: Why Are These Small-Cap Shares Up While Broader Sector Is In The Red?

Four lesser-valued cannabis stocks showed positive performance on Monday, defying the broader sector's downtrend. These stocks—Medical Marijuana Inc., TILT Holdings, Trees Corp., and Village Farms International —present potential investment opportunities.

ACB

Read More

Weed Industry Celebrates Biden’s Rescheduling Move: ‘Most Monumental Cannabis Reform In Half A Century’

Cannabis companies and advocates applaud President Biden's announcement to reschedule and legalize cannabis, calling it a major leap forward and opportunity to correct long-standing wrongs and improve the industry's cashflow.

ACB